LXEO
Lexeo Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.76
+4.55%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.37x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 1.01x
Liquidity & coverage
- Current ratio
- 13.89x
- Quick ratio
- 13.89x
- Cash ratio
- 13.49x
- Interest coverage
- -689.25x
- EBITDA / interest
- -615.63x
- Working capital
- $202.2M
Cash & dividend
- FCF / debt
- -13.02x
- Cash flow / debt
- -12.97x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026